-
1.
The publication of a generic drug in a pharmaceutical database before the expiry date of the patent constitutes an infringement under Art. 53 Dutch Patent Act.
-
2.
The term “to offer” in Art. 53 Dutch Patent Act must be interpreted in a broad sense.
This is a preview of subscription content, log in via an institution to check access.
Author information
Consortia
Additional information
For the original, see http://www.iept.nl/files/2010/IEPT20101102_Hof_Den_Haag_Glaxo_Group_v_Pharmachemie.pdf.
Translated by Nicole van der Laan, PhD candidate, Max Planck Institute for Innovation and Competition, Munich.
Rights and permissions
About this article
Cite this article
Decision of the Supreme Court (Hooge Raad) 22 June 2012 and The Hague Court of Appeal 2 November 2010. “G-Standard”. IIC 45, 973–976 (2014). https://doi.org/10.1007/s40319-014-0275-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40319-014-0275-y